11 results
Insulin Analogs - Short, Intermediate and Long Acting - Onset, Peak, Duration

#Diabetes #Insulin #Analogs #Onset #Duration
, Duration #Diabetes ... Peaks #Comparison #Pharmacology ... #Endocrinology ... #Timing #Timeline
Mechanism of Action for Common Diabetes Medications

 • SGLT2i (Dapagliflozin)
 • TZD (Pioglitazone)
 • Biguanides (Metformin)
Action for Common Diabetes ... GLP-1 Receptor Agonists ... sarahthelyon #Diabetes ... #Medications #pharmacology ... pathophysiology #endocrinology
The principles of insulin adjustment guidance - Schematic diagram of insulin onset and time action profiles
and Duration #Diabetes ... Peaks #Comparison #Pharmacology ... #Endocrinology ... #Timing #Timeline
The graph illustrates the differences in the onset and duration of action for various types of
Detemir, Glargine #Diabetes ... Duration #Peaks #Timeline ... Graph #Comparison #Pharmacology ... #Endocrinology
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
GLP-1 Agonists ... to treat Type 2 Diabetes ... #Pharmacology #Dosing ... #Diabetes #DM2 ... #Endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... GLP-1 receptor agonist ... insulin in Type 1 Diabetes ... #Medications #pharmacology ... comparison #table #endocrinology
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
GLP-1 Receptor Agonists ... - Pharmacology ... #Pharmacology # ... Summary #DM2 #diabetes ... #endocrinology
DPP-4 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits DPP-4 (dipeptidyl peptidase 4), which normally inactivates GLP-1
4 Inhibitors - Pharmacology ... GLP-I receptor agonist ... DPP4 #Inhibitors #Pharmacology ... #Summary #DM2 #diabetes ... #endocrinology
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
First Oral GLP-1 Agonist ... Otherwise, it works ... #semaglutide #Diabetes ... #Pharmacology # ... Endocrinology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... These work by inhibiting ... SGLT2 #Inhibitors #Pharmacology ... Medications #DM2 #Diabetes ... #Endocrinology